Paid Clinical Trials in Omaha, NE
As of September 2026, 581 paid clinical trials are recruiting in Omaha, Nebraska. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Omaha offers studies at sites including University of Nebraska Medical Center for conditions such as Breast Cancer, Prostate Cancer, Multiple Myeloma, Non-Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Omaha
Trials by drug in Omaha
Filter results
Newly added in Omaha
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
A Study of V132 in Healthy Older Participants (V132-001)
528 clinical trials
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Top Research Study Locations in Omaha
Researchers run research studies in Omaha, NE at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Nebraska Medical Center | Acute Myeloid Leukemia, Multiple Myeloma, Breast Cancer | 220 |
| Nebraska Cancer Specialists | Breast Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer | 40 |
| Nebraska Medicine-Village Pointe | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 | 40 |
| Children's Hospital and Medical Center of Omaha | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 27 |
| Nebraska Methodist Hospital | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 25 |
| Alegent Health Bergan Mercy Medical Center | Malignant Solid Neoplasm, Plasma Cell Myeloma, Prostate Adenocarcinoma | 22 |
| Alegent Health Immanuel Medical Center | Malignant Solid Neoplasm, Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma | 20 |
| Alegent Health Lakeside Hospital | Malignant Solid Neoplasm, Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma | 20 |
| Nebraska Cancer Specialists/Oncology Hematology West PC - MECC | Ovarian Carcinoma, Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma | 13 |
| Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE | Chronic Obstructive Pulmonary Disease, Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD) | 13 |
| University of Nebraska | Adenovirus Infections, Brain Tumor, Brain Tumor - Metastatic | 12 |
| Creighton University Medical Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 10 |
| Creighton University | Age-associated Muscle Loss, Anxiety and Mood Disorders, Bilateral Vestibular Hypofunction | 8 |
| Boys Town National Research Hospital | Developmental Language Disorder, Autism, Autism Spectrum Disorder | 7 |
| Nebraska Medicine | Cachexia, Choline Deficiency, Engagement | 7 |
| Children's Nebraska | Acute Kidney Injury, Bronchiolitis Acute, Chronic Kidney Disease(CKD) | 6 |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 6 |
| GSK Investigational Site | Colonic Neoplasms, Gastrointestinal Neoplasms, Gastrointestinal Stromal Neoplasms | 5 |
| Nebraska Medical Center | Atrial Fibrillation, Cardiac Arrest, Cardiopulmonary Arrest | 5 |
| Unversity of Nebraska Medical Center | Chronic Pancreatitis, Diabetes Mellitus, Type 2, Genetic Predisposition to Disease | 4 |
| Oncology Hematology West, PC dba Nebraska Cancer Specialists | Follicular Lymphoma (FL), Metastatic Castration Resistant Prostate Cancer (mCRPC), Refractory Diffuse Large B-cell Lymphoma | 4 |
| Children's Hospital & Medical Center | Acute Treatment of Migraine, Pediatric Migraine | 3 |
| Fred & Pamela Buffet Cancer Center | Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT), Diffuse Large B-Cell Lymphoma, Prostate Adenocarcinoma | 3 |
| Vance Thompson Vision | Age-Related Macular Degeneration, Astigmatism, Geographic Atrophy | 3 |
| Velocity Clinical Research, Omaha | COVID-19 SARS-CoV-2 Infection, Clostridoides Difficile Associated Disease, Cortisol Excess | 3 |
Active & Upcoming Studies in Omaha (2026)
Recruiting trials in Omaha grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (252 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · University of Nebraska
Cardiovascular (38 active studies)
- Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest · Phase 3 · Invero Pharma, Inc.
- Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids · Phase 1, Phase 2 · University of Nebraska
Diabetes & metabolic (19 active studies)
- AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications · Phase 3 · Novo Nordisk A/S
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight · Phase 3 · AstraZeneca
Neurology & pain (15 active studies)
- Clinical Validation of Self-Pacing Algorithms on Step Length Symmetry in Hemiplegic Populations · Quality Living, Inc.
- The Impact of Enhanced Music & Natural Visuals on Emotional Health · soundBrilliance LLC
Pediatric (8 active studies)
- Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy · University of Nebraska
- iAmHealthy Clinical Practice Guideline (CPG) · University of Kansas Medical Center
Eye & vision (6 active studies)
- A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK · Phase 4 · Vance Thompson Vision
- The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma · Vance Thompson Vision
Vaccines (5 active studies)
Mental health & behavior (4 active studies)
- The Impact of Enhanced Music & Natural Visuals on Emotional Health · soundBrilliance LLC
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) · Bristol-Myers Squibb
HIV / STI (2 active studies)
Common conditions studied in Omaha
- Breast Cancer (16 active studies)
- Prostate Cancer (14 active studies)
- Multiple Myeloma (13 active studies)
- Non-Small Cell Lung Cancer (11 active studies)
- Ovarian Cancer (10 active studies)
- Heart Failure (9 active studies)
Leading research sponsors in Omaha
- University of Nebraska
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Omaha?
There are approximately 581 recruiting clinical trials in Omaha, Nebraska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Omaha pay participants?
Most recruiting trials in Omaha compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Omaha?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Omaha?
The most common conditions under active study in Omaha include Breast Cancer (16), Prostate Cancer (14), Multiple Myeloma (13), Non-Small Cell Lung Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Omaha?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Omaha on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Omaha?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Omaha?
Recruiting research sites in Omaha include University of Nebraska Medical Center, Nebraska Cancer Specialists, Nebraska Medicine-Village Pointe, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Omaha right now?
The largest active categories in Omaha are Cancer & tumors (252), Cardiovascular (38), Diabetes & metabolic (19). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.